About Us
Our mission
Drug development is becoming unprofitable more than before. This can mainly be attributed to large average development costs, low clinical trial drugs success rate, and low ROI because of reduced healthcare expenditure and focused on rare diseases. However, AI can be applied in drug discovery to make the process faster significantly and statistically. As a result, innovative technologies have been creating an environment where medical advances can be quickly realized.
Based on our own unique technology and extensive data, we are constantly challenging ourselves with a mission to conquer incurable diseases and deliver healthy life and happiness to countless suffering patients.
Our history
Since our establishment in November 2017,
Arontier has been selected for various projects and collaborations, establishing itself as a prominent corporation in the field of AI-driven drug discovery. We’ve recently launched our own AI-based drug discovery service platform, further enhancing our capabilities and contributing to the advancement of treatments for incurable and rare diseases.
SINCE 2017
SINCE 2017
Our history
Since our establishment in November 2017,
Arontier has been selected for various projects and collaborations, establishing itself as a prominent corporation in the field of AI-driven drug discovery. We’ve recently launched our own AI-based drug discovery service platform, further enhancing our capabilities and contributing to the advancement of treatments for incurable and rare diseases.
Our leadership
Arontier is an activist and a realist,
to overcome the challenges of disease through technology and innovation, grounded in real-world evidence. Our approach emphasizes open communication and collaboration, not only in developing new medicines but also in genetic editing, working closely with domestic and international companies, experts, and scholars. We prioritize human health and the happiness of individuals as our ultimate goal.
